ATLAS holds up 10-year tamoxifen regime
Results from the ATLAS study indicate that women with estrogen receptor-positive breast cancer should consider taking tamoxifen for up to 10 years after diagnosis. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - December 10, 2012 Category: Cancer & Oncology Source Type: news
Breast cancer overdiagnosis concerns for USA
Around a third of screening-detected breast cancers in US women in 2008 may have been overdiagnosed, suggests research published in The New England Journal of Medicine. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - November 26, 2012 Category: Cancer & Oncology Source Type: news
Exercise relieves cancer fatigue
A review of studies spanning 45 years shows that exercise, particularly aerobic rather than strength- or flexibility-based training, improves fatigue in cancer patients. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - November 21, 2012 Category: Cancer & Oncology Source Type: news
